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Abstract
Lipid droplets (LDs) are dynamic cytoplasmic organelles containing neutral lipids and bounded by a phospholipid
monolayer. Previous studies have suggested that LDs can undergo constitutive homotypic fusion, a process linked to the
inhibitory effects of fatty acids on glucose transporter trafficking. Using strict quantitative criteria for LD fusion together
with refined light microscopic methods and real-time analysis, we now show that LDs in diverse cell types show low
constitutive fusogenic activity under normal growth conditions. To investigate the possible modulation of LD fusion, we
screened for agents that can trigger fusion. A number of pharmacological agents caused homotypic fusion of lipid droplets
in a variety of cell types. This provided a novel cell system to study rapid regulated fusion between homotypic phospholipid
monolayers. LD fusion involved an initial step in which the two adjacent membranes became continuous (,10 s), followed
by the slower merging (100 s) of the neutral lipid cores to produce a single spherical LD. These fusion events were
accompanied by changes to the LD surface organization. Measurements of LDs undergoing homotypic fusion showed that
fused LDs maintained their initial volume, with a corresponding decrease in surface area suggesting rapid removal of
membrane from the fused LD. This study provides estimates for the level of constitutive LD fusion in cells and questions the
role of LD fusion in vivo. In addition, it highlights the extent of LD restructuring which occurs when homotypic LD fusion is
triggered in a variety of cell types.
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Introduction
Cells store excess fatty acids as neutral lipids such as
triglycerides (TG) and cholesteryl esters in unique structures called
lipid droplets (also termed lipid bodies). Lipid droplets (LDs) are
proposed to form from the cytoplasmic leaflet of the endoplasmic
reticulum, and eventually bud to generate discrete organelles
bounded by a phospholipid monolayer and containing the cellular
machinery required to regulate the deposition and catabolism of
neutral lipids [1,2,3]. LDs have recently been ascribed many of the
functional characteristics of bona fide cellular organelles including
microtubule-based motility [4,5,6,7,8], fusion [9,10,11] and
interaction with other organelles including the ER [12],
peroxisomes [13], endosomes [14], mitochondria [15] and
caveolae [5,16].
One of the characteristic features of LDs is their specific size and
distribution, which can vary considerably between different cell
types. LDs can enlarge through both addition of neutral lipids to
pre-existing LDs [17,18] or through microtubule-dependent fusion
[9,10]. However, when fatty acid levels are elevated LDs
frequently form as clusters of similarly sized organelles [5,19],
and in model cell lines such as 3T3-L1 adipocytes large numbers
of LDs pack closely together [20], suggesting that unregulated
fusion of LDs does not readily occur. The size of LDs relates to
both the amount of stored neutral lipid, which is the net result of
TG synthesis (lipogenesis) and hydrolysis (lipolysis), and the
regulation of lipolysis by external factors. Recent studies imply
that LD size and distribution can change in states of lipid related
disease. Troyer syndrome, a neurological disease, is associated
with a truncated form of the ubiquitin ligase binding protein
Spartin (also called SPG20). Overexpression of Spartin induced
LD clustering in the perinuclear region whereas knockdown of
Spartin increased both the number and size of oleic acid induced
LDs [21]. Other types of motor neuron disorders, as well as
Berardinelli-Seip congenital lipodystrophy, arise from mutant
forms of Seipin (Fld1p), a protein which when deleted in yeast
caused fusion of LDs and increased levels of neutral lipids [22].
The neutral lipid storage disease Chanarin-Dorfman syndrome
(CDS), which is characterised by the accumulation of LDs in many
tissues, is linked to mutations in comparative gene identification-58
(CGI-58). CGI-58 interacts with adipose triglyceride lipase
(ATGL), the rate-limiting enzyme for TAG catabolism, and
increases its lipase activity [23]. Knockdown of CGI-58 in
preadipocytes significantly increased the number of LDs [24]
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average LD size [25,26]. Similarly, highly enlarged LDs are
present in drosophila nurse cell clones with a mutant form of
Widerborst, a negative regulator of PI3K/PTEN/Akt associated
with diabetes, obesity and some cancers [27]. Together these
studies imply constant and tightly controlled regulation of LD size
under normal conditions across many cell types, which may break
down in disease states.
In view of the number of published studies linking LD size to
different functional states, we have investigated the properties of
LDs in fibroblasts and in adipocytes by quantitative real-time
microscopy. Using the same conditions used in previous studies
but refined microscopic techniques we now show that LDs in
diverse cell types exhibit low fusogenic activity under normal
growth conditions. By screening a variety of pharmacological
agents for their ability to alter LD homeostasis we have identified a
number of reagents with similar chemical structures that stimulate
homotypic fusion of LDs, possibly by localised membrane
disruption. This allowed us to validate our refined light
microscopic methods to study LD fusion and to carry out a
detailed study of the fusion process in living cells. These studies
provide new insights into the dynamic regulation of this crucial
lipid storage organelle while providing new methods for their study
in different pathophysiological states.
Materials and Methods
Cell culture
3T3-L1 fibroblasts (American Type Culture Collection, Rock-
ville, MD) were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% (v/v) fetal calf serum (Hyclone/
Invitrogen) and 2 mM L-glutamine (Invitrogen), differentiated
using insulin, dexamethasone, biotin, and isobutyl-methylxanthine
as described previously [28] and used between days 6–12 post-
differentiation. Where required, adipocytes were detached from
the dishes using 0.05% trypsin and electroporated at 960 mF,
0.16 kV (BioRad Gene Pulser II and Capacitance Extender Plus)
for ,20 ms with 100 mg of DNA on day 8 post-differentiation.
NIH-3T3 and BHK-21 cells (American Type Culture Collection,
Rockville, MD) were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% (v/v) fetal calf serum and 2 mM
L-glutamine. Transfection of NIH-3T3s was performed using
Lipofectamine Plus (Gibco/Invitrogen) according to the manu-
facturer’s instructions.
Antibodies, plasmids and reagents
Rabbit anti-Phospho PKA Substrate (RRXS/T) (catalog
no. 9624) was obtained from Cell Signaling Technology, rabbit
anti-perilipin A (catalog no. P1998) and mouse anti-a-tubulin
clone DM 1A (catalog no. T9026) were obtained from Sigma.
Alexa488- and Alexa594-conjugated secondary antibodies were
obtained from Molecular Probes Inc. (Eugene, OR). Perilipin A-
YFP was kindly provided by Dr J. Granneman, Wayne State
University School of Medicine, Michigan, U.S.A. Bodipy 493/
503 and Nile Red were obtained from Molecular Probes and
prepared as saturated solutions in ethanol (working dilution,
1:200) and acetone (working dilution, 1:2000), respectively. Oleic
acid was obtained from Calbiochem and conjugated to fatty-acid
free bovine serum albumin prior to use. Forskolin and ML-7 were
obtained from Merck and reconstituted according to manufac-
turer’s instructions. TrypLExpress was obtained from Invitrogen.
All other reagents were obtained from Sigma unless stated
otherwise.
Indirect immunofluorescence microscopy and Real-time
video microscopy
Indirect immunofluorescence microscopy was performed as
described previously [4]. The data were processed using the LSM
510 Meta software (Zeiss), and images were assembled using
Photoshop CS3 (Adobe Systems, Mountain View, CA). Cells for
real-time microscopy were plated onto glass bottomed tissue
culture dishes (MatTek Corp.) or 25 mm round glass coverslips
and transferred into CO2-independent medium (Invitrogen)
supplemented with 0.1% fatty-acid free BSA (Calbiochem).
NIH-3T3 cells were incubated for 2 h or overnight in 50 mg/ml
oleic acid prior to imaging. When used Bodipy 493/503 was
diluted 1:4000 directly to the imaging medium 10 min prior to
commencement of imaging. Reagents were diluted in 1 ml
medium and added to 3 ml medium covering cells prior to
imaging at a final concentration of 50 mM. Cells were used for
real-time data collection for a maximum of 1 hr.
For 4D imaging, time series were collected at 37uC using
Axiovert 200 M SP LSM 510 META or 710 META confocal laser
scanning inverted microscopes equipped with a 63x oil immersion
objective (numerical aperture, NA=1.4) and a heated stage which
held the glass bottomed tissue culture dishes (MatTek Corp.)
containing the cells. Z-stack confocal images were taken at 30 s
intervals using AIM v3.2 or Zen 2009 software (Zeiss). 4D image
analysis of LD motility and clustering in MEF and NIH-3T3
fibroblasts was performed on 30–200 LDs from at least 4 cells from
two experiments. 4D image analysis of LD fusion in NIH-3T3s
was performed on 50–230 LDs from 5 or more cells across at least
3 replicates using Imaris v7 software to track individual LDs over
time. LDs were tracked using the ‘surface’ tool in Imaris with
smooth area detail level of 0.1–0.5 mm, size of largest sphere was
0.5–1.5 mm (dependent on average LD size, ,0.7 mm for NIH-
3T3), background subtraction thresholding (local contrast) of 20–
40 mm( ,20 mm for MEFs, ,30 mm for NIH-3T3), default
number of voxels, and tracking was performed using a Brownian
motion algorithm with a maximum track distance of 20 mm and a
maximum gap size of 2 mm. Analysis of 4D images to determine
LD surface area and volume is described in detail below (Statistical
and mathematical analysis).
2D time series images were collected at 37uC using Personal
Deltavision software with an Olympus IX81 inverted microscope
fitted with a Roper Cool Snap HQ
2 monochrome camera, Axyos
technologies heated block which held 22 mm round glass
coverslips on which the cells were grown and 100x (NA=1.4) or
60x (NA=1.42) oil immersion objectives. Image analysis of LD
number following treatment with reagents in NIH-3T3s was
performed on 10 or more cells over 4 experiments and LD size was
measured for the largest LD per cell from 15 cells each from 5
experiments. At least 3 live-cell imaging experiments were
performed using each fusogenic reagent. Analysis of LD fusion
events triggered by increasing concentrations of H-89 was
performed on 3 or more cells for each concentration in two cell
types. Alternatively, cells were imaged using an Olympus IX71
inverted microscope fitted with Imago Super VGA 12bit CCD
SensiCam (T.I.L.L Photonics), Axyos technologies heated block
which held 22 mm round glass coverslips on which the cells were
grown and 100x oil immersion objective (NA=1.4). Time series
images were collected using a 470 nm excitation laser filter with an
exposure time of 80–100 ms or by bright field microscopy. Image
analysis of one and two stage fusion events was performed on 70 or
more fusion events from more than 20 cells. Where relevant
deconvolution was performed using Personal Deltavision software
with the default autoregression algorithm over 10 iterations. All
images were converted to 8-bit TIFF files and further analyzed
Lipid Droplet Fusion
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MD) or Imaris v7 software. QuickTime videos were assembled
using ImageJ 1.37p or Imaris v7, and still images were compiled
using Adobe Photoshop CS3.
Mathematical and Statistical Analysis
Analysis of the volume and surface area associated with LD
fusion was conducted on fusion events which were defined either
as two droplets in one frame becoming one droplet in the
subsequent frame in all dimensions (rendered 3D or ortho slice of
the LDs at their largest apparent diameter) or where the surfaces
of the two initial droplets became continuous in the resulting
droplet (i.e. using perilipin A-YFP). In both cases, the resulting
droplet had to remain a single entity in every following frame. As
analysis of confocal z-stack images demonstrated that the lipid
droplets were spherical, surface area (S.A.=2pr
2) and volume
(V=4/3pr
3) were calculated from the radii of individual droplets,
as measured in the x–y plane bisecting the largest apparent
diameter of the LD. Subsequently volumes and surface areas of the
two initial droplets were compared by linear regression to those of
the final droplet. To analyze lipid droplet fusion under various
treatments, live cells were imaged and a student’s t-test (paired)
was used to compare average lipid droplet number per cell
between the first and last frames (4–5 videos/treatment).
In fixed cells, measurement of the lipid droplet radii through
one x–y plane was used to derive lipid droplet dimensions from
micrographs. Between 500–1200 lipid droplets were analysed in
.200 cells from randomly chosen fields and differences compared
using an unpaired student t-test (two tailed, unequal variance).
Analysis of LD number was performed using a particle analysis
tool in Image J to identify LDs with a circularity of 0.8–1.
Western blotting
SDS-PAGE and Western blot analysis was carried out
essentially as described previously [4]. Briefly cells were lysed in
10 mM Tris/150 mM NaCl/5 mM EDTA, pH 7.4, containing
phosphatase and proteinase inhibitors (Roche), and solubilised in
Laemmli sample buffer containing 25 mM DTT. Immunolabeled
proteins were visualized using HRP-conjugated secondary anti-
bodies and developed using the Supersignal ECL reagent (Pierce/
Quantum Scientific).
Results
Analysis of constitutive LD fusion: a quantitative 3D
characterization
Despite many reports of LD clustering and studies of LD
dynamics in a variety of cell types, few observations of LD fusion
have been reported [9,10,11,18,29,30]. To examine LD dynamics
and interactions we first utilised mouse embryonic fibroblasts
(MEFs), which are characterized by extremely thin cytoplasmic
regions and so are conducive to live cell imaging. The cells were
incubated with 50 mg/ml oleic acid for 2 hr prior to imaging to
increase the size and number of LDs, and treated with Bodipy 493/
503 to label the neutral lipid components throughout the core of the
droplet. Z-stack images of live cells were acquired every 30 s over a
30 min period using time-lapse confocal fluorescence microscopy.
Previous studies have shown that LDs undergo microtubule-based
motility [4,5,6,31] although the degree of LD movement varies with
cell type (for review see [32]). Tracking of individual LDs in MEFs
showed an average track length of 9.5 mm63.3 mm but an average
displacement of only 2.2 mm60.3 mm (Fig. 1a, Video S1),
indicating that LDs in MEFs exhibit very little directional
movement. LDs were highly clustered with an average of 65% of
LDs in close proximity (within 300 nm) to another LD. LDs are
commonly visualised by staining the neutral lipid core with
fluorescent dye that allows clusters of LDs to be readily resolved
into individual components when imaged through the x–y axis. The
resolution of individual LDs could be further enhanced by
deconvolution (Fig. 1b). However, the resolution of individual
LDs within a cluster was lost when z-stack images were collapsed (in
the z axis) or surface rendered. These techniques generally resulted
in clusters of LDs appearing as large irregular structures and LDs in
close proximity to one another to appearing as a single entity
(Fig. 1c). In order to analyse LD dynamics in Bodipy-stained cells, a
combination of 2D and 3D visualisation was used. Despite the
extensive LD clustering observed in MEFs no LDs appeared to
undergo fusion in the observed time frame.
Studies by Bostrom and colleagues reported constitutive LD
fusion in NIH-3T3 fibroblasts [10]. To determine if the difference
in reported LD fusion in NIH-3T3s and the lack of observed LD
fusion in MEFs could be related to a difference in LD motility or
clustering, analysis of LD dynamics in NIH-3T3s was performed
as described above (using conditions identical to those reported by
Bostrom et al [10]). LDs in NIH-3T3 fibroblasts were found to
travel an average of 6.660.4 mm with an average displacement of
2.960.4 mm, similar to LD motility observed in MEFs. NIH-3T3
cells also showed a similar level of LD clustering as seen in MEFs
with an average of 52% of LDs in close proximity to one another
(Fig. 1d). To examine the dynamics of LD fusion, z-stack images of
live cells were acquired over 5 min periods using time-lapse
confocal fluorescence microscopy and subsequently collapsed (in
the z plane) or surface rendered to produce 2D and 3D images,
respectively. Analysis of LD interactions was performed using the
criteria for fusion as outlined by Bostrom et al [10] (two initial
droplets are not more than 3.5 mm apart, the volume of the
resulting droplet must not exceed the combined volume of the two
initial droplets by more than 50% and must be present in the
timepoint following fusion without a change in volume). Many of
the LDs were closely associated with other LDs during the capture
time and 2.160.9% of the total number of LDs appeared to fuse
as defined by the above criteria. However, analysis in the z-plane
of the apparently fused LDs revealed irregular profiles, not readily
discernible in the x–y plane, which were not consistent with the
more spherical profile of unfused droplets (Fig. 1e, left panel) or
droplets formed when fusion was triggered (see below for examples
of triggered fusion). Further analysis of each ‘fused’ droplet
observed in the 3D rendered cells showed that 69.9% of ‘fused’
droplets were clearly separate entities when viewed in unrendered
x–y planes through a z-stack. In addition, although we were able
to observe a ‘waist-like’ structure between LDs prior to fusion in
3D rendered cells, these structures were not apparent when the
LDs were analysed in single x–y planes (Fig. 1f). In light of the
discrepancies between ‘fused’ droplets when visualised in different
planes, and in comparison to unequivocal fusion events observed
when the cells were treated with a variety of agents (see below) we
established the following criteria to define LD fusion in this system;
[1] fused LDs persist as a single entity for the remainder of the
capture time (which must be no less than half the image capture
time, here 2.5 min), as expected for a stable fusion event, [2] over
that period no discontinuity between fused LDs is observed in
either the x–y or the x-z-axis and [3] the resulting droplet becomes
increasingly spherical as fusion progresses (irregularities in LD
shape do not persist for more than 2 min). Using these criteria, in
our hands no unequivocal fusion events were observed in NIH-
3T3 cells imaged over 5–30 min, suggesting that constitutive
homotypic LD fusion is a rare event and is likely to be tightly
regulated.
Lipid Droplet Fusion
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To begin to examine the dynamic regulation of LDs we
screened a number of inhibitors of protein kinases (eg. protein
kinase A, PKA; extracellular signal-regulated kinase, ERK) or
upstream receptors (b-adrenergic receptors, b-ARs) for their
effects on LD size and number in NIH-3T3 fibroblasts (Table 1).
To screen for LD fusion, NIH-3T3s were incubated in 50 mg/ml
oleic acid overnight to generate large numbers of mature LDs,
Figure 1. Imaging lipid droplet fusion in NIH-3T3 cells. (a) Bodipy493/503 stained MEFs were imaged using time-lapse fluorescent z-stack
confocal microscopy for 30 min. Tracking of the LDs using Imaris software demonstrated that the LDs underwent little directional motility. Tracks are
shown through time from blue to white. Bar=5 mm. (b) Images of Bodipy493/503 stained NIH-3T3s were deconvolved to increase the resolution of
individual LDs. Bar=10 mm. (c) 3D rendering of Bodipy493/503 stained LDs in close proximity can produce a single entity (arrows). Bar=1 mm. (d)
50% of the LDs in NIH-3T3s are found in clusters (arrows). Bar=10 mm. (e) Examples of juxtaposed LDs (yellow) which appear to fuse and have a
spherical profile as viewed in the x–y plane of rendered LDs but have a highly irregular profile in the x–z plane. Bar=1.5 mm. (f) The appearance of a
‘waist-like’ structure between two rendered LDs in the x–z and x–y planes is absent when viewed in a single unrendered x–y plane. Bar=1 mm.
N=nuclei.
doi:10.1371/journal.pone.0015030.g001
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503. Randomly selected micrographs were deconvolved and the
cells analysed for LD number and size.
The initial reagent screen revealed that treatment with H-89,
ML-7, propranolol and SR 59230A resulted in a significant
reduction in LD number with a concurrent increase in average LD
size, indicative of LD fusion (Figure 2a, b). To confirm that the LD
remodelling seen in the fixed cells was the result of LD fusion,
rather than increased lipid accumulation in LDs or inhibition of
LD fission or catabolism, time-lapse z-stack imaging of live cells
was performed. No detectable alteration in the structure of LDs,
including fission or fusion events, was observed in NIH-3T3 cells
stained with Bodipy493/503 during prolonged imaging (up to
30 min) under control conditions (Fig. 2c). However, treatment
with 50 mM H-89 (Figure 2d, Video S2), 50 mM ML-7, 50 mMS R
59230A and 200 mM propranolol triggered fusion of adjacent LDs
as defined by the above criteria, where the LD contents merged to
form a single droplet with a spherical profile in all planes, as well as
cell rounding (data not shown). Fusion was only observed in cells
treated with reagents at well above physiologically relevant
concentrations ($50 mM). Treatment of NIH-3T3 and baby
hamster kidney (BHK-21) cells with increasing concentrations of
H-89 showed inhibition of phospho-PKA substrate phosphoryla-
tion was at least partly achieved with 10 mM H-89 whereas
homotypic LD fusion only occurred at concentrations of 50 mMo r
above (Figure S1a). Furthermore, the rate of LD fusion appeared
to be concentration dependent as 100 mM H-89 triggered a 6-fold
increase in the number of fusion events over cells treated with
50 mM H-89 (Figure S1b). In addition, LD fusion events were not
observed in cells treated with less than 200 mM propranolol (data
not shown) despite inhibition of both the b1- and b2-ARs being
achieved at much lower concentrations [33]. Together these data
suggest that LD fusion was triggered by some other property of the
reagents, for example biophysical properties, rather than simply
the inhibition of their respective targets. Despite the ambiguity
surrounding the mechanism of action of these drugs, we have
identified H-89, ML-7, propranolol and SR 59230A as effective
triggers of homotypic LD fusion.
To fully validate homotypic fusion of LDs (where the surfaces of
the initial droplets become continuous and the contents merge)
from possible docking events (where the LDs are in close contact
but do not become one droplet), Perilipin A-YFP (Plin A-YFP) was
used as a marker of the LD surface. A monolayer marker produces
more reliable results than staining the LD core with a fluorescent
dye, particularly as imaging through the LD in single x–y planes
allows demonstration of the continuation of the membranes during
LD fusion. When expressed in NIH-3T3 cells Plin A-YFP localised
to the surface of all detectable LDs as judged by Nile Red staining
(Fig. 2e) and a net increase in number and mean LD size was
observed (data not shown), consistent with previous studies [34].
However, overexpression of Plin A-YFP did not cause LD fusion
within the timeframes studied here, as judged by phase contrast
microscopy and by the use of the Bodipy dye (data not shown).
Simultaneous phase-contrast and fluorescent imaging showed
adjacent cells with and without expression of Plin A-YFP
underwent LD fusion with similar kinetics when treated with
50 mM H-89 (Data not shown), demonstrating that expression of
Plin A-YFP had no observable influence on LD fusion. Further
analysis of fusion between Plin A-YFP-labelled LDs showed
continuation of the LD membrane following fusion.
Stimulated fusion of lipid droplets in adipocytes
We next investigated the characteristics of chemical-induced LD
fusion in 3T3-L1 adipocytes. Unlike fibroblasts, which contain tens
of small LDs (,1 mm diameter), 3T3-L1 adipocytes contain a
number of large, perinuclear LDs (5–10 mm diameter), which
makes them ideal for detailed analysis of the dynamics of
monolayer-monolayer fusion, as occurs between fusing LDs. Live
cell imaging was performed to determine if the fusogenic reagents
identified in the fibroblast screen could trigger LD fusion in 3T3-
L1 adipocytes. Analysis of brightfield time-lapse images of 3T3-L1
adipocytes showed low motility and no fusion events under control
conditions (Fig. 3a). However, treatment with 50 mM H-89 (Video
S3), ML-7 (Fig. 3a) or SR 59230A (Video S4) triggered the rapid
fusion of adjacent LDs (Fig. 3a). Further analysis of 3T3-L1
adipocytes treated with H-89 showed that LD fusion was triggered
in all cells observed. LD fusion appeared temporally regulated,
with fusion occurring 16.662.6 min after the addition of H-89
and reaching an apparently stable state (no further fusion events)
after 42.463.1 min. Detailed analysis was also performed on both
single slice and z-stack real-time images of 3T3-L1 adipocytes
expressing Plin A-YFP. In control cells Plin A-YFP labelled LDs
showed very little motility and no detectable fusion within a
45 min time period (Fig. 3b). In contrast, over the same time
period treatment with 200 mM propranolol resulted in multiple
LD fusion events in over 80% of cells analysed (Fig. 3b, Video S5,
detail Video S6). Fusion triggered by propranolol was temporally
regulated, similar to that observed in H-89 treated cells. Individual
fusion events occurred rapidly initiating approximately 45 min
after addition of propranolol, before the LDs again entered an
apparently stable state. Fusion triggered by SR 59230A (50 mM), a
selective b3-AR antagonist, also followed a similar pattern with
fusion ceasing 34.664.1 min after initiation. Imaging of Plin A-
YFP labelled LDs in a single x–y slice clearly showed continuation
of the membrane during fusion triggered by SR 59230A (Fig. 3c).
In addition to triggering LD fusion, treatment with H-89, ML-7,
propranolol and SR 59230A all induced cell rounding. To
determine if cell rounding itself, through loss of adhesion to the
substratum or disruption of the cytoskeleton, could trigger LD
fusion 3T3-L1 adipocytes were treated with nocodazole to disrupt
the microtubule network, cytochalasin D to disrupt the actin
network or trypsin to detach cells from the substratum. Treatment
Table 1. Agents screened for lipid droplet fusion activity.
Reagent Targets
H-89 PKA, S6K1, ROCK-II, MSK-1, PKBa, AMPK, PKG, CaCMK-II,
MLCK, ERK1/2, PRK2, RSK1/2, PKD1
ML-7 MLCK, MSK-1
Propranolol B-adrenergic receptors
SR 59230A B3-adrenergic receptor
U0126 MEK, PRAK, SAPK2a/2b
KT5720 PKA, PDK-1, MEK, MSK-1, PKBa
BIM-I PKC isoforms
Primary targets highlighted in bold. PKA, cAMP-dependent protein kinase; S6K1,
p70 ribosomal protein S6 kinase 1; ROCK-II, Rho-dependent protein kinase II;
MSK-1, mitogen- and stress-activated protein kinase 1; PKBa, protein kinase B a;
AMPK, AMP-activated protein kinase; PKG, cGMP -dependent protein kinase;
CaCMK-II, calcium/calmodulin-dependent protein kinase II; MLCK, myosin light
chain kinase; ERK1/2, extracellular-signal-related kinase 1/2; PRK2, protein
kinase C-related protein kinase 2; RSK1/2, p90 ribosomal protein S6 kinase;
PKD1, serine-threonine protein kinase D1; MEK, MAPK kinase (also called MKK);
PRAK, p38-regulated/activated kinase; SAPK2a, stress-activated protein kinase
2a (also called p38); SAPK2b, stress activated protein kinase 2b (also called
p38b2); PDK-1, 3-phosphoinositide-dependent protein kinase 1; PKC, protein
kinase C; BIM-I, bisindolylmaleimide I.
doi:10.1371/journal.pone.0015030.t001
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cytoskeleton but did not alter LD morphology (Figure S2a) or
increase LD volume (Figure S2b). No LD fusion was observed in
time-lapse images of 3T3-L1 adipocytes treated with the above
reagents for up to 30 min (data not shown). In addition, the
microtubule network was not required for LD fusion to occur.
Disruption of the microtubule network with nocodazole did not
prevent LD fusion in cells subsequently treated with 200 mM
propranolol (Figure S2). Together this data suggests that LD fusion
is not a direct result of cell rounding.
Taken together the results suggest that defined chemicals can
trigger LD fusion in a specific fashion but that this effect is likely to
be unrelated to their properties as kinase inhibitors. This ability of
these fusogenic chemicals to trigger LD fusion in 3T3-L1
adipocytes was subsequently used as a model system with which
to study the dynamics of LD fusion in vivo.
Lipid droplet fusion occurs in two stages
Real-time fluorescence microscopy of live cells was undertaken to
examine the characteristics of homotypic LD fusion. 3T3-L1
adipocytes with and without ectopic expression of Plin A-YFP were
used as model systems in which to analyse individual fusion events
triggered by the addition of H-89 or SR 59230A. Detailed analysis
of fusion by fluorescence microscopy in Plin A-YFP expressing cells
and by brightfield microscopy in untransfected cells revealed two
populations of fusing LDs; those in which fusion was completed and
the resulting droplet was spherical within 10 s (1 frame) (72.9% and
75.3% of total fusion events in untransfected and transfected cells,
respectively) and those where fusion appeared to occur in two
stages: an initial rapid fusion of the surfaces of the two LDsto form a
continuous membrane within 10 s (1 frame), followed by a slower
merging of the contents and the reformation of a single round LD
which occurred over 10 s to 17.5 min (27% and 24.7% of total
fusion events in untransfected and transfected cells, respectively)
(Fig. 4a, Video S7). In both transfected and untransfected cells, the
majority of two-stage fusion events reformed spherical droplets
within 100 s of initial fusion of the membranes (90% in
untransfected cells, 67% in Plin A-YFP expressing cells), although
a small number of droplets in the Plin A-YFP expressing cells took
up to 17.5 min to regain a spherical shape, as judged by the
circularity of the LD surface in a single x–y plane.
Lipid droplet surface rearrangement occurs both prior to
and following lipid droplet fusion
Under control conditions Plin A-YFP in fibroblasts and
adipocytes uniformly localised to the LD surface and formed a
continuous ring in a single x–y slice (Fig. 4b). Following treatment
with fusogenic reagents a marked redistribution of Plin A-YFP over
the surface of the LDs was observed, with the formation of dense
patches of Plin A-YFP prior to LD fusion (Fig. 4b, Video S8), or the
directional redistribution of Plin A-YFP on LDs that did not
subsequently undergo fusion for the duration of imaging (30 min)
(Fig. 4c). Post-fusion, Plin A-YFP was observed to redistribute into
large, discrete structures on the surface of the fused LD, often
appearing fixed at the site of fusion (Fig. 4d). Prolonged imaging of
fused droplets showed that these dense Plin A-YFP structures
persisted for over 30 min. Despite the redistribution of Plin A-YFP
on the LD surface, the LD itself remained intact and spherical, as
determined by 3D rendering of fixed cells and visualisation of the
lipid core by Nile Red staining (Fig. 4e).
Volume but not surface area is conserved during lipid
droplet fusion
LDs assume a spherical shape in 3T3-L1 adipocytes consistent
with a low surface area to volume ratio, as seen in 3-dimensional
rendering of z-stack confocal images (Fig. 5a). Fusion of two
spheres must result in a sphere with either the same volume or the
same surface area as the two initial spheres. To determine whether
surface area (membrane) or volume was conserved during LD
fusion, we analysed the change in volume and surface area of
resulting fused LDs relative to the two donor LDs. We measured
the volumes and surface areas of 60 pairs of donor LDs in live cells
and used these values to predict the volume of the resulting LD,
assuming either volume or surface area conservation. To
determine how closely the predicted volumes matched the actual
volumes, the two sets of predicted volumes were plotted against the
measured volumes of the resulting LDs (Fig. 5b). In the case where
the volumes of the two donor LDs were conserved, we showed a
linear relationship between the predicted and measured volumes
with a slope of 1, demonstrating that the predicted volumes of the
resulting LDs closely match the actual volumes. However, where
the surface areas of the donor LDs were conserved, the slope of the
trend line was 0.71, showing that the predicted volumes of the
resulting LDs were larger than the actual volumes. Together, this
demonstrated that the volume of the two donor LDs was
conserved during fusion (Fig. 5b). Modelling of fusion between
LDs of a range of sizes indicated that the fused LDs achieved a
minimal volume with a resulting loss of up to 22% of the combined
starting surface area, within 30sec of the fusion event (Fig. 5c). As
LDs are constrained within a limiting phospholipid monolayer
these data suggest that either phospholipids are rapidly removed
from the LD following fusion, or that significant compaction of the
LD phospholipid monolayer can occur.
Discussion
The processes governing LD biology are currently under intense
scrutiny as many metabolic diseases have been associated with
changes in LD distribution, function and size. The formation of
LDs in some cell types, especially macrophages, liver and muscle,
is associated with the progression of increasingly common
metabolic diseases such as insulin resistance, type II diabetes and
cardiovascular disease. In order to elucidate the mechanisms
behind changes in LD morphology in disease states it is necessary
to develop a more complete understanding of the fundamental
biology of LDs. Of particular interest is the regulation of LD size.
It is well documented that an increase in fatty acids leads to the
formation of tightly packed clusters of similarly sized LDs
[5,11,18,19] which are able to function as discrete organelles
[6]. However, fusion of LDs has been observed very rarely
[18,29,30], with few exceptions [9,10,11]. This suggests that if
Figure 2. Lipid droplet fusion can be triggered specifically by chemicals. (a) Representative images NIH-3T3 cells treated with a variety of
chemical reagents and stained with Bodipy493/503. Bar=10 mm, N=nucleus. The chemical structure of each reagent appears beside the image. (b)
Random micrographs from each reagent treatment were analysed for both LD size and number. Fusogenic reagents caused a decrease in LD number
concurrent with an increase in LD radius. Error bars represent the S.E.M of at least 12 cells from 3 or more replicates, *p,0.0005, **p,0.005,
***p,0.05. (c) Prolonged imaging of LDs using Bodipy493/503 in NIH-3T3 cells failed to detect LD fusion. Bar=5 mm, N=nucleus (d) Time-lapse
imaging of NIH-3T3 cells stained with Bodipy493/503 demonstrated that multiple fusion events were triggered by addition of 50 mM H-89. Coloured
arrows indicate fusing pairs of LDs. Bar=10 mm (e) Plin A-YFP was expressed in NIH-3T3 cells and the LDs detected using Nile Red. Bar=10 mm.
doi:10.1371/journal.pone.0015030.g002
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highly regulated event. As LD size (volume) is very consistent
within a specific cell type, fusion would have to be balanced by
rapid removal of neutral lipids from the newly formed droplet or
as yet unobserved subsequent fission events (which would require
additional monolayer formation). Although homotypic LD fusion
has been observed in 3T3-L1 cells undergoing differentiation [35],
this process is likely to be tightly controlled as the large LDs
present in mature differentiated 3T3-L1 adipocytes pack tightly
together without resulting in constitutive LD fusion. Regulated
fusion of LDs has been shown to occur in Drosophila S2 cells
lacking Cct1 or Cct2, proteins involved in phospholipid synthesis.
Figure 3. Fusion can be triggered in 3T3-L1 adipocytes. (a) 3T3-L1 adipocytes were replated and imaged in real-time using bright field
microscopy for a total of 30 min. No LD fusion events were observed when cells were treated with vehicle (DMSO). However, addition of 50 mMS R
59230A, 50 mM H-89 or 50 mM ML-7 triggered fusion of LDs (arrows in blow-up) and cell rounding. Bar=20 mm. (b) Perilipin A-YFP was transiently
expressed in 3T3-L1 adipocytes and imaged by real-time microscopy in the absence or presence of 200 mM propranolol. Z-stack confocal microscopy
images were acquired every 30 s over 45 min and rendered to produce a 3D image of the cell. There was no significant motility or detectable fusion
of labelled LDs in control cells. Following treatment with 200 mM propranolol, multiple LD fusion events were observed in over 80% of the cells
expressing perilipin A-YFP. Many LDs underwent multiple fusion events, highlighted in the sequential fusion of three LDs (insert). Bar=10 mm,
insert=2 mm. (c) 3T3-L1 cells transiently expressing Plin A-YFP were imaged in a single plane during treatment with 50 mM SR 59230A. The
membranes of the two fusing LDs became continuous within 10 s and the LD cores had merged within 30 s. Bar=20 mm, blow-up=10 mm.
doi:10.1371/journal.pone.0015030.g003
Lipid Droplet Fusion
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15030Knockdown of other genes involved in phospholipid biosynthesis
(CK, HLH106, SCAP and FAS) also resulted in an increase in LD
size concurrent with a decrease in LD number, presumably due to
LD fusion [11]. From studies in COS7 cells, treatment with fatty
acid or palmitate induces LD formation which is associated with
an increase in the amount of phosphatidylcholine (PC) (as well as
TG and diacylglycerol) in the LD fraction [18]. As PC is limiting
in Cct1 knockdown cells, it has been suggested that a decrease in
PC, along with an increase in the relative amount of phosphati-
dylethanolamine may promote LD fusion to decrease the surface
area to volume ratio, limiting the requirement for PC for
membrane synthesis [11].
Although unregulated LD fusion has not been readily observed
in most cell types, recent studies by Bostrom et al [9,10] show
constitutive fusion of approximately 15% of the total LDs in NIH-
3T3 cells at any given time. These fusion events have been shown
to be microtubule dependent and mediated by SNARE proteins
[9,10]. Although this study showed a striking difference in the
apparent size and distribution of the LDs in SNAP23 knockdown
cells compared to control conditions [9], our results suggest that
this treatment may alter clustering or docking of LDs rather than
fusion. The methods described here can now be applied to the
question of SNARE-mediated LD regulation and to the study of
other proteins proposed to regulate homotypic fusion of LDs.
As no examples of unequivocal LD fusion were observed under
control conditions, we screened for reagents that may modulate
LD fusion. Here we have shown that a variety of pharmacological
reagents at used at high concentrations can trigger homotypic LD
fusion in both fibroblasts and adipocytes. Treatment with 50 mM
H-89, 50 mM ML-7, 50 mM SR 59230A and 200 mM propranolol
each triggered rapid fusion of adjacent LDs. Each of these reagents
have different documented primary targets and a number of listed
off-target effects [36,37,38,39]. Comparison of the structures of the
fusogenic reagents to those which did not trigger fusion revealed
the presence of a naphthalene group (two benzene rings joined in
the ortho position) in three of the four fusogenic reagents; H-89,
ML-7 and propranolol. The presence of a naphthalene group in a
molecule creates a highly hydrophobic region which has been
shown to insert into the hydrophobic core of a lipid bilayer
[40,41,42]. A study of the mechanism of action of propranolol on
artificial membranes showed that propranolol disrupts the outer
phospholipid monolayer of liposome bilayers prior to the
formation of ‘worm-like micelles’ [43]. In addition, treatment of
liposomes with low concentrations of propranolol resulted in
Figure 4. Lipid droplet fusion occurs in two stages and the lipid droplet surface is disrupted upon treatment with fusogenic
reagents. (a) 3T3-L1 adipocytes expressing perilipin A-YFP were imaged in real-time for a total of 30 min. Analysis of single fusion events in 3T3-L1
adipocytes treated with 50 mM SR 59230A showed that the initial fusion (defined by the continuity of the LD membranes) was completed within 1
frame (30 s) whereas the reformation of a spherical structure could take several minutes. Bar=10 mm. (b) H-89 (50 mM final concentration) was added
directly to the medium whilst imaging (Bar=20 mm). Prior to any LD fusion being observed, Plin A-YFP redistributed into dense patches on the LD
surface (arrows). Bar=10 mm. (c) In adipocytes treated with SR 59230A the directional loss of Plin A-YFP across the surface of the LDs was observed.
Bar=10 mm. (d) An example of the appearance of a discrete, intensely fluorescent structure at the site of LD fusion. Bar=10 mm. (e) 3D rendering of z-
stack images show the LD core (stained with Nile Red) remains spherical although the surface has been disrupted (as seen by Plin A-YFP labelling).
Bar=5 mm.
doi:10.1371/journal.pone.0015030.g004
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interactions between the propranolol and proteins on the liposome
surface. Treatment of the same liposomes with high concentrations
of propranolol destabilised the liposomal membranes causing them
to lyse [44]. This may explain the observation that fusion occurs in
3T3-L1 adipocytes treated with 200 mM propranolol but not
100 nM propranolol (data not shown). Together this data leads to
the possibility that some of the fusogenic reagents found in our
screen trigger LD fusion at high concentrations at least in part
through insertion into, and local disruption of, the LD phospho-
lipid monolayer. This hypothesis is in agreement with the
observation that triggered LD fusion only occurs between adjacent
LDs, rather than trafficking of LDs towards one another prior to
fusion as would be expected for functionally regulated LD fusion.
However, a similar mechanism of local membrane disruption may
be utilised by the cell on a small scale to allow homotypic fusion to
occur in specialised scenarios, such as the reformation of large LDs
from microLDs produced during stimulated lipolysis in adipocytes.
Figure 5. Modelling and analysis of individual lipid droplet fusion events. Sequential confocal images taken through the z-axis and
subsequent 3D rendering of the z-stack clearly show the spherical shape adopted by perilipin A-YFP containing LDs in 3T3-L1 adipocytes. Bar=2 mm.
(b) LD volumes were calculated following 60 individual fusion events and plotted against the predicted volume, assuming either conserved volume
(dark grey circles) or conserved surface area (light grey squares) of the initial LD. The data were analysed by linear regression and the best fit in each
case designated by a solid line. The equation of the trend line, and R-squared value is displayed adjacent to each data set. Analysis clearly
demonstrated that the best fit was attained when the volume was conserved (slope of the line=1). (c) Schematic modelling of LD fusion
demonstrates the excess surface area generated by fusion when volume is conserved.
doi:10.1371/journal.pone.0015030.g005
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of action of the fusogenic reagents, this study demonstrates that
LD fusion can occur and we were able to use this system to
perform detailed analysis of the unique dynamics arising from
fusion between monolayer membranes within the cell.
Using the fusogenic reagents found in our screen allowed us to
characterise LD fusion. In the majority of treated cells the LDs
underwent rapid homotypic fusion with adjacent LDs, reaching an
apparently stable state approximately 30 min after fusion was first
observed. This temporal regulation may be the result of saturation
of a system or pathway in the fusion process, or the resulting
droplets being too far apart to undergo further fusion events.
Approximately a quarter of the fusion events recorded progressed
via a two-step process where the initial membrane fusion was
observed within 10 s, followed by the gradual merging of the LD
contents over 10 s to 17.5 min. Addition of fusogenic reagents also
induced LD surface rearrangement prior to and following LD
fusion, which may be further indication that the fusogenic reagents
trigger fusion by disrupting the LD membrane. Plin A-YFP on the
LD surface was seen to form dense patches upon the addition of
fusogenic reagents, leaving areas of the surface without Plin A-
YFP. Furthermore, following fusion Plin A-YFP often decorated
the site where fusion had occurred with stable, large and intensely
fluorescent patches. One possibility is that these intense patches of
Plin A-YFP labelling denote flaps of excess membrane generated
through LD fusion. Modelling of LD fusion based on measure-
ments of LD size during fusion showed that the volume of the two
initial droplets was conserved in the final fused droplet, which can
be predicted to generate excess membrane. Regulated LD fusion
in control cells could therefore provide membrane phospholipids if
required for other cellular processes. This would also generate
larger LDs, which have a more efficient surface area to volume
ratio for lipid storage. Although constitutive LD fusion in basal
cells will remain controversial, we have shown that LD fusion can
occur in both fibroblasts and adipocytes though in our hands this
occurs only when triggered by the addition of fusogenic reagents
and is likely to be the result of LD surface disruption. However, the
possibility remains that under specific conditions cellular processes
may disrupt the LD surface in order to facilitate regulated fusion.
This raises the possibility that tightly regulated partial fusion with
bilayered organelles could also occur [45] We propose that this
mechanism could allow precise regulation of the ‘hemifusion’
between LDs and other organelles, as has been suggested to occur
between LDs and early endosomes [14], facilitating the direct
transfer of LD-associated proteins or lipid components for either
oxidation in mitochondria, efflux from the cell surface, conversion
to phospholipids in the ER or the transfer of fatty acids from the
late endosomes/lysosomes. Spatiotemporal regulation of LD
fusion suggests a mechanism by which monolayer-monolayer
and monolayer-bilayer interactions could be controlled and
represents a unique and powerful model system with which to
study membrane interactions in vivo.
Supporting Information
Figure S1 The fusogenic effect of H-89 is concentration
dependent. (a) BHK cells were treated with increasing
concentrations of H-89 and subsequently stimulated with
Forskolin and IBMX for 30 min. Whole cell lysates were western
blotted for phospho-PKA substrates and tubulin. Representative of
3 experiments. (b) Time-lapse imaging of NIH-3T3s stained with
Bodipy493/503 (Bar=5 mm) showed a 6-fold increase in the
number of fusion events per cell in cells treated with 100 mM H-89
over cells treated with 50 mM H-89. Error bars represent the
S.E.M of at least 10 cells per condition from two experiments.
*p,0.05.
(TIF)
Figure S2 Cell rounding does not trigger LD fusion. (a)
3T3-L1 adipocytes were treated for 30 min with 44 mM
nocodazole and either fixed directly in ice-cold methanol for
3 min, or further treated with 200 mM propranolol for 1 hr prior
to fixation. Cells were labelled for a-tubulin and perilipin A, and
the nuclei detected using DAPI. Bar=20 mm (b) Cells treated as in
(a) were fixed in 4% PFA, labelled for perilipin A and stained with
DAPI. The average volume of LDs/cell is the percentage change
relative to the control volume in two different experiments. Error
bars represent the S.D. of 500–1200 cells from at least 3 replicates.
*p,0.001.
(TIF)
Video S1 Mouse embryonic fibroblast treated with oleic acid
overnight and stained with Bodipy493/503. Z-stack confocal
image taken at 1 frame per 30 s, volume rendered. Coloured lines
indicate LD movement over time.
(MOV)
Video S2 NIH-3T3 treated with oleic acid overnight and stained
with Bodipy493/503. Z-stack confocal image taken at 1 frame per
minute, volume rendered. Treatment with 50 mM H-89 triggered
fusion of adjacent LDs (examples circled).
(MOV)
Video S3 3T3-L1 adipocytes imaged by brightfield microscopy
at 1 frame per 10 s. Treatment with 50 mM H-89 triggered
dramatic fusion of adjacent LDs.
(MOV)
Video S4 3T3-L1 adipocytes imaged by brightfield microscopy
at 1 frame per 10 s. Treatment with 50 mM SR 59230A triggered
extensive fusion of adjacent LDs (examples circled).
(MOV)
Video S5 3T3-L1 adipocyte expressing Plin-YFP imaged at 1
frame per minute. Z-stack confocal image, rendered. Treatment
with 200 mM propranolol triggered fusion of adjacent LDs.
(MOV)
Video S6 Detail of LD fusion taken from Video S7 shows
sequential fusion of adjacent LDs.
(MOV)
Video S7 Expression of Plin A-YFP in a 3T3-L1 adipocyte
showed continuation of the LD membranes during fusion
triggered by treatment with 50 mM SR 59230A. Fluorescent
image taken at 1 frame per 10 s.
(MOV)
Video S8 Plin A-YFP redistributed on the LD surface in a 3T3-
L1 adipocyte both prior to, and following LD fusion triggered by
treatment with 50 mM SR 59230A. Fluorescent image taken at 1
frame per 10 s.
(MOV)
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